These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24526133)

  • 21. AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.
    Boot E; Booij J; Hasler G; Zinkstok JR; de Haan L; Linszen DH; van Amelsvoort TA
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1350-6. PubMed ID: 18283451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice.
    Ralph RJ; Varty GB; Kelly MA; Wang YM; Caron MG; Rubinstein M; Grandy DK; Low MJ; Geyer MA
    J Neurosci; 1999 Jun; 19(11):4627-33. PubMed ID: 10341260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder.
    Vulink NC; Planting RS; Figee M; Booij J; Denys D
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):350-356. PubMed ID: 26711686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory gating in rats depleted of dopamine as neonates: potential relevance to findings in schizophrenic patients.
    Schwarzkopf SB; Mitra T; Bruno JP
    Biol Psychiatry; 1992 Apr; 31(8):759-73. PubMed ID: 1643192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
    Peng RY; Mansbach RS; Braff DL; Geyer MA
    Neuropsychopharmacology; 1990 Jun; 3(3):211-8. PubMed ID: 2141986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Density of striatal D2 receptors in untreated first-episode psychosis: an I123-IBZM SPECT study.
    Corripio I; Escartí MJ; Portella MJ; Pérez V; Grasa E; Sauras RB; Alonso A; Safont G; Camacho MV; Dueñas R; Arranz B; San L; Catafau AM; Carrió I; Alvarez E
    Eur Neuropsychopharmacol; 2011 Dec; 21(12):861-6. PubMed ID: 21470832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans.
    Mann C; Croft RJ; Scholes KE; Dunne A; O'Neill BV; Leung S; Copolov D; Phan KL; Nathan PJ
    Neuropsychopharmacology; 2008 Jun; 33(7):1653-66. PubMed ID: 17895917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.
    Corripio I; Pérez V; Catafau AM; Mena E; Carrió I; Alvarez E
    Neuroimage; 2006 Jan; 29(2):662-6. PubMed ID: 16112587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.
    Swerdlow NR; Geyer MA; Shoemaker JM; Light GA; Braff DL; Stevens KE; Sharp R; Breier M; Neary A; Auerbach PP
    Neuropsychopharmacology; 2006 Mar; 31(3):506-15. PubMed ID: 16123772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.
    Braak B; Booij J; Klooker TK; van den Wijngaard RM; Boeckxstaens GE
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):642-50. PubMed ID: 22160229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats.
    Crunelle CL; de Wit TC; de Bruin K; Ramakers RM; van der Have F; Beekman FJ; van den Brink W; Booij J
    Nucl Med Biol; 2012 Jul; 39(5):640-4. PubMed ID: 22261145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG; Gil R; Hackett E; Mawlawi O; Zea-Ponce Y; Zhu Z; Kochan LD; Cangiano C; Slifstein M; Gorman JM; Laruelle M; Abi-Dargham A
    Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
    Boesch SM; Donnemiller E; Müller J; Seppi K; Weirich-Schwaiger H; Poewe W; Wenning GK
    Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large single ethnicity study of prepulse inhibition in schizophrenia: Separate analysis by sex focusing on effect of symptoms.
    Matsuo J; Ota M; Hori H; Hidese S; Teraishi T; Ishida I; Hiraishi M; Kunugi H
    J Psychiatr Res; 2016 Nov; 82():155-62. PubMed ID: 27505440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorder.
    Kasanova Z; Ceccarini J; Frank MJ; van Amelsvoort T; Booij J; van Duin E; Steinhart H; Vaessen T; Heinzel A; Mottaghy F; Myin-Germeys I
    Psychol Med; 2018 Aug; 48(11):1909-1914. PubMed ID: 29233195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
    Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat.
    Salum C; Guimarães FS; Brandão ML; Del Bel EA
    Psychopharmacology (Berl); 2006 Apr; 185(2):133-41. PubMed ID: 16402193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.
    Quednow BB; Wagner M; Westheide J; Beckmann K; Bliesener N; Maier W; Kühn KU
    Biol Psychiatry; 2006 Mar; 59(6):536-45. PubMed ID: 16139819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.